Evogene (EVGN) Misses Q4 EPS by 5c

Evogene (NYSE: EVGN) reported Q4 EPS of ($0.22), $0.05 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $2.46 million versus the consensus estimate of $3.9 million.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• Braze stock tumbles 10% on weak third quarter EPS guidance
• ServiceTitan, Inc. (TTAN) Misses Q2 EPS by 1c, Offers Guidance